Fig. 7.
![Fig. 7. Ca2+ responses to specific PAR-2 and TR agonists. Indo-1–loaded cells were stimulated with either the PAR-2–specific agonist SLIGKV (120 μmol/L; solid line) or the TR-specific agonist TFRIFD (120 μmol/L; dotted line), and intracellular [Ca2+] was measured using a spectrofluorimeter. (A) MEG-01; (B) Jurkat; (C) J.RT-T3.5 (TCR-negative); and (D) J.CaM1/rep3 (lck-deficient).](https://ash.silverchair-cdn.com/ash/content_public/journal/blood/90/5/10.1182_blood.v90.5.1893/4/bl_0018f7.jpeg?Expires=1735843719&Signature=mFkhd9vfUkQhFRRACn2i3s8OEcE0K-GsD58awl2Lux7BEOi44pFE~5gU97ydpPSsL7dedcd29vSIs7Q-wGEpWn1RWtANvJ3uyDxwzBq2ZkPoE4~UPAyWMnY7bpxH9xN6ONTjtkbQOaqLMFTKhgkOo-vH~00dXTvHH0yodLxUCJ3-LPSVQxXM7zO1pAhrzhXwNQgDI89IVu-6aKF0VMFUuYW8G1hnKhMkn8tXZe6Joh-CuymlHzWpxDRt~jTX6DFr2Bh3Zho7evKCOHa~KQ134xhbqMPmbhhrzWzUItIQomb2O6w0n5uZ8qzfk~kB4-wNqM62gMzwz76n~pflfQhogQ__&Key-Pair-Id=APKAIE5G5CRDK6RD3PGA)
Ca2+ responses to specific PAR-2 and TR agonists. Indo-1–loaded cells were stimulated with either the PAR-2–specific agonist SLIGKV (120 μmol/L; solid line) or the TR-specific agonist TFRIFD (120 μmol/L; dotted line), and intracellular [Ca2+] was measured using a spectrofluorimeter. (A) MEG-01; (B) Jurkat; (C) J.RT-T3.5 (TCR-negative); and (D) J.CaM1/rep3 (lck-deficient).
